InvestSMART

BPH Global Ltd (ASX:BP8)

ALERT: Price-sensitive ASX Announcement for BP8
Current share price for BP8 : $0.002 0 (0%)+
Announcement
Release
7 May 2026 9:44AM
Price at Release
$0.002
Full Release
download
Summary
BPH Global Ltd announced the execution of a testing agreement with Temasek Innovation Holdings Pte Ltd for Project Giddy-Up, targeting male vitality through a seaweed-based formulation. The program involves a two-stage, cell-based efficacy testing regime aimed at validating biological activity across male vitality pathways. This initiative supports the company's regulatory strategy for listing on the Australian Register of Therapeutic Goods as a complementary medicine. The agreement outlines deliverables, IP ownership, and a structured timeline through October 2026.
Key Points
  • Binding services agreement executed with Temasek Innovation Holdings Pte Ltd (TPIH) for Project Giddy-Up
  • Commencement of a two-stage, cell-based efficacy testing program
  • The product is aimed at male vitality, anti-fatigue, stress recovery, and sleep/wellness support
  • Seaweed-based formulation signifies a novel approach in the men's health nutraceutical sector
  • Testing to validate biological activity across key male vitality pathways
  • Agreement includes defined deliverables, IP ownership, and timeline through October 2026
  • Supports AUST L (TGA) pathway for men’s health supplement
  • Program involves PDE-5 inhibition assay, nitric oxide and cGMP pathway analysis, and testosterone production assessment
  • Comparison of two formulations for efficacy and safety
  • Material terms include scope, term, fees, deliverables, IP ownership, confidentiality, and termination rights
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.